The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Predicting Antimicrobial Resistance in Invasive Pneumococcal Infections
Abstract
BACKGROUND: The prevalence of multiantimicrobial resistance among Streptococcus pneumoniae continues to increase worldwide. In patients presenting with infection possibly due to pneumococci, recognition of risk factors that would identify those likely to have an antibiotic-resistant isolate might assist clinicians in choosing the most appropriate empirical therapy. METHODS: A prospective cohort study of invasive pneumococcal infection was conducted in Toronto, Canada. Risk factors for antimicrobial resistance were evaluated by means of univariate and multivariate modeling. RESULTS: A total of 3339 patients with invasive pneumococcal infection were identified between 1995 and 2002. Multivariate modeling revealed that risk factors for infection with penicillin-resistant as opposed to penicillin-susceptible pneumococci were year of infection (odds ratio [OR], 1.28; P < .001), absence of chronic organ system disease (OR, 1.72; P = .03), and previous use of penicillin (OR, 2.47; P = .006), trimethoprim-sulfamethoxazole (TMP-SMX; OR, 5.97; P < .001), and azithromycin (OR, 2.78; P = .05). Infection with TMP-SMX-resistant pneumococci was associated with absence of chronic organ system disease (OR, 1.64; P = .001) and with previous use of penicillin (OR, 1.71; P = .03), TMP-SMX (OR, 4.73; P < .001), and azithromycin (OR, 3.49; P = .001). Infection with macrolide-resistant isolates was associated with previous use of penicillin (OR, 1.77; P = .03), TMP-SMX (OR, 2.07; P = .04), clarithromycin (OR, 3.93; P < .001), and azithromycin (OR, 9.93; P < .001). Infection with fluoroquinolone-resistant pneumococci was associated with previous use of fluoroquinolones (OR, 12.1; P < .001), current residence in a nursing home (OR, 12.9; P < .001), and nosocomial acquisition of pneumococcal infection (OR, 9.94; P = .003). CONCLUSIONS: Knowledge of antimicrobial use during the 3 months before infection is crucial for determining appropriate therapy for a patient presenting to the hospital with an illness for which S. pneumoniae is a possible cause. Nosocomial acquisition and nursing home acquisition are significant risk factors for infection with fluoroquinolone-resistant pneumococci.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Niederman, M. S., Mandell, L. A., Anzueto, A., Bass, J. B., Broughton, W. A., Campbell, G. D., Dean, N., File, T., Fine, M. J., Gross, P. A., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.at1010 · Cited by 2,150
Mandell, L. A., Bartlett, J. G., Dowell, S. F., File, T. M., Musher, D. M., & Whitney, C. (2003) · Clinical Infectious Diseases · doi:10.1086/380488 · Cited by 1,004
Decreased Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada
Chen, D. K., McGeer, A., de Azavedo, J. C., & Low, D. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410403 · Cited by 987
Self-citationQuality of Care, Process, and Outcomes in Elderly Patients With Pneumonia
Meehan, T. P. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550230056037 · Cited by 919
Mandell, L. A., Marrie, T. J., Grossman, R. F., Chow, A. W., Hyland, R. H., & and the Canadian Community-Acquired Pneumonia Working Group (2000) · Clinical Infectious Diseases · doi:10.1086/313959 · Cited by 664
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.2.223 · Cited by 589
Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia
Davidson, R., Cavalcanti, R., Brunton, J. L., Bast, D. J., de Azavedo, J. C. S., Kibsey, P., Fleming, C., & Low, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012122 · Cited by 533
Self-citationYu, V. L., Chiou, C. C. C., Feldman, C., Ortqvist, A., Rello, J., Morris, A. J., Baddour, L. M., Luna, C. M., Snydman, D. R., Ip, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/377534 · Cited by 451
Pallares, R., Gudiol, F., Liñares, J., Ariza, J., Rufi, G., Murgui, L., Dorca, J., & Viladrich, P. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707023170104 · Cited by 373
Lonks, J. R., Garau, J., Gomez, L., Xercavins, M., Ochoa de Echagüen, A., Gareen, I. F., Reiss, P. T., & Medeiros, A. A. (2002) · Clinical Infectious Diseases · doi:10.1086/341978 · Cited by 324
Granizo, J. J. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.5.767 · Cited by 173
Clavo‐Sanchez, A. J., Giron‐Gonzalez, J. A., Lopez‐Prieto, D., Canueto‐Quintero, J., Sanchez‐Porto, A., Vergara‐Campos, A., Marin‐Casanova, P., & Cordoba‐Dona, J. A. (1997) · Clinical Infectious Diseases · doi:10.1086/513628 · Cited by 172
Bedos, J.-P., Chevret, S., Chastang, C., Geslin, P., Regnier, B., & French Cooperative Pneumococcus Study Group (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.1.63 · Cited by 167
Samore, M. H., Magill, M. K., Alder, S. C., Severina, E. P., Boer, L. M.-D., Lyon, J. L., Carroll, K. C., Leary, J., Stone, M. B., Bradford, D. C., et al. (2001) · PEDIATRICS · doi:10.1542/peds.108.4.856 · Cited by 146
Gay, K., Baughman, W., Miller, Y. K., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315853 · Cited by 126
Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany
Reinert, R. R. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.61 · Cited by 123
Luján, M., Gallego, M., Fontanals, D., Mariscal, D., & Rello, J. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000114817.58194.bf · Cited by 122
A Nosocomial Outbreak of Fluoroquinolone‐ResistantStreptococcus pneumoniae
Weiss, K., Restieri, C., Gauthier, R., Laverdière, M., McGeer, A., Davidson, R., Kilburn, L., Bast, D. J., de Azavedo, J., & Low, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/322658 · Cited by 115
Self-citationFluoroquinolone‐ResistantStreptococcus pneumoniaeAssociated with Levofloxacin Therapy
Urban, C. M., Rahman, N. A., Zhao, X., Mariano, N., Segal‐Maurer, S., Drlica, K., & Rahal, J. J. (2001) · The Journal of Infectious Diseases · doi:10.1086/323086 · Cited by 110
Macrolide‐ResistantStreptococcus pneumoniaeand Use of Antimicrobial Agents
Pihlajamäki, M., Kotilainen, P., Kaurila, T., Klaukka, T., Palva, E., Huovinen, P., & the Finnish Study Group for Antimicrobial Resistance (FiRe‐Network) (2001) · Clinical Infectious Diseases · doi:10.1086/322735 · Cited by 94
Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in Canada during 2000
Low, D. E., de Azavedo, J., Weiss, K., Mazzulli, T., Kuhn, M., Church, D. L., Forward, K. R., Zhanel, G. G., Simor, A. E., & McGeer, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1295-1301.2002 · Cited by 93
Self-citationKays, M. B., Smith, D. W., Wack, M. F., & Denys, G. A. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.5.395.33185 · Cited by 93
The Pneumococcus at the Millennium: Not Down, Not Out
AUSTRIAN, R. C. (1999) · The Journal of Infectious Diseases · doi:10.1086/513841 · Cited by 82
García-Rey, C., Aguilar, L., Baquero, F., Casal, J., & Martin, J. E. S. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.8.2959-2963.2002 · Cited by 59
Antimicrobial Resistance in Streptococcus pneumoniae, Taiwan
Hsueh, P., & Luh, K. (2002) · Emerging infectious diseases · doi:10.3201/eid0812.020178 · Cited by 49
Update on community-acquired pneumonia: impact of antibiotic resistance on clinical outcomes
Metlay, J. P. (2002) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200204000-00011 · Cited by 40
de Galan, B. E., van Tilburg, P. M. B., Sluijter, M., Mol, S., de Groot, R., Hermans, P. W. M., & Jansz, A. R. (1999) · Journal of Hospital Infection · doi:10.1053/jhin.1999.0580 · Cited by 38
Cited by
Resistance to Antibiotics: Are We in the Post-Antibiotic Era?
Alanis, A. J. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.06.009 · Cited by 1,417
Chow, A. W., Benninger, M. S., Brook, I., Brozek, J. L., Goldstein, E. J. C., Hicks, L. A., Pankey, G. A., Seleznick, M., Volturo, G., Wald, E. R., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir1043 · Cited by 501
Antiviral Therapy and Outcomes of Influenza Requiring Hospitalization in Ontario, Canada
McGeer, A., Green, K. A., Plevneshi, A., Shigayeva, A., Siddiqi, N., Raboud, J., Low, D. E., & Toronto Invasive Bacterial Diseases Network (2007) · Clinical Infectious Diseases · doi:10.1086/523584 · Cited by 398
Self-citationLappin, M. R., Blondeau, J., Boothe, D., Breitschwerdt, E. B., Guardabassi, L., Lloyd, D. H., Papich, M. G., Rankin, S. C., Sykes, J. E., Turnidge, J., et al. (2017) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14627 · Cited by 374
Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use
Dalhoff, A. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/976273 · Cited by 354
Metadata
- Authors
- Vanderkooi, O. G., Low, D. E., Green, K., Powis, J. E., McGeer, A., & for the Toronto Invasive Bacterial Disease Network
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-01
- Volume
- 40
- Issue
- 9
- Pages
- 1288-1297
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W1995231765
- Cited by
- 257
- References
- 30
- FWCI
- 18.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.